Bernd Schlereth

Company: Araris Biotech AG

Job title: Chief Development Officer

Seminars:

Workshop A: Selecting an ADC Target Receptor to Reduce On-Target Off-Tumor Toxicities 9:30 am

Discovering a way to direct more of your ADC towards the tumor and less onto the organ of toxicity and off-tumor receptor sites will allow for a huge increase of your ADC candidates’ therapeutic index. Take part in this deep dive into ADC target selection to learn how to select the correct target receptor, resulting…Read more

day: Workshop Day